Ignite Creation Date:
2024-05-06 @ 7:46 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06125769
Status:
RECRUITING
Last Update Posted:
2024-01-24
First Post:
2023-10-30
Brief Title:
LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma LITALHICA
Sponsor:
Azienda Sanitaria Ospedaliera
Organization:
Azienda Sanitaria Ospedaliera
Study Overview
Official Title:
LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma LITALHICA
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LITALHICA
Brief Summary:
LITALHICA is a prospective non-randomized study aimed at exploring the outcome of liver transplantation in selected patients with unresectable perihilar cholangiocarcinoma pCCA after treatment with standard of care chemotherapy in terms of overall survival and quality of life Additionally the study aims to identify pre-transplant biological markers and clinical factors that can stratify patients with the best post-transplant prognosis Finally the study aims to investigate the role of preoperative PET-MRI especially in relation to lymph node locations by correlating the results with histological examination after hilar lymphadenectomy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None